Missed Periods: When to See a Doctor

Missing a period, medically called amenorrhea, is common and often harmless when it happens once. The question that actually matters is not whether a missed period is dangerous in general, but which specific trigger it meets: how many cycles have been missed, whether pregnancy has been excluded, and whether any accompanying symptom (galactorrhea, severe pelvic pain, hot flashes under age 40) points to something that should not wait.

Missed periods for three or more consecutive months (secondary amenorrhea), or no first period by age 15 with otherwise normal puberty (primary amenorrhea), meet the threshold clinicians use to start an evaluation. Pregnancy should be ruled out first with a urine or serum hCG test regardless of how unlikely conception seems, because the next steps in a workup differ depending on that result. Beyond pregnancy, the leading causes in reproductive-age women are polycystic ovary syndrome (PCOS), thyroid dysfunction, elevated prolactin, and hypothalamic suppression from low energy availability or stress. These categories and thresholds reflect long-standing obstetric and gynecologic practice guidance rather than a single study, and a clinician usually narrows the cause with a small set of blood tests and a pelvic ultrasound.

This article describes general patterns in amenorrhea evaluation and management. It is not a substitute for an individualized evaluation, and it does not provide personal diagnosis or dosing instructions. If you are missing periods and trying to conceive, are under 18, or have symptoms below in the "red flag" list, talk to a clinician rather than trying to self-diagnose from a symptom list.

Terms Used in This Article

• Primary amenorrhea: no period by age 15 with otherwise normal pubertal development, or no periods and no pubertal signs by age 13.
• Secondary amenorrhea: absence of periods for three or more consecutive months in someone who previously had cycles.
• Oligomenorrhea: cycles that occur but are spaced more than 35 days apart. This is a related but distinct pattern from amenorrhea.
• Hypothalamic amenorrhea (HA): loss of periods caused by suppressed signaling from the brain to the ovaries, typically driven by low caloric intake relative to energy expenditure, heavy exercise, or significant psychological stress.
• Premature ovarian insufficiency (POI): loss of normal ovarian function before age 40, distinct from natural menopause, which is diagnosed later in life.

What Counts as a Missed Period Worth Evaluating?

A typical menstrual cycle runs about 21 to 35 days. Skipping a single period once is common and, in isolation, rarely a sign of disease. Missing three or more consecutive cycles, or going 90 days or more without a period, is the point at which clinical guidance generally recommends evaluation. In adolescents, no period by age 15 with normal breast and pubic hair development also warrants a referral, because some causes (chromosomal conditions, anatomic obstruction) benefit from earlier rather than later diagnosis.

Cycle tracking for two to three months before an appointment, using an app or a paper calendar, gives a clinician real data instead of an estimate, which can shorten the workup.

Common Causes of Missed Periods

Pregnancy is excluded first in essentially every evaluation. After that, causes generally fall into four groups: hormonal disorders, anatomic problems, systemic illness, and lifestyle or medication effects.

Pregnancy and the Postpartum Period

A sensitive urine hCG test can turn positive within roughly two weeks of conception, and a serum beta-hCG is more sensitive still. Even when pregnancy seems very unlikely, testing before further workup is standard practice because it changes which tests make sense next. Amenorrhea during exclusive breastfeeding (lactational amenorrhea) is a normal, expected physiologic state for a period of months post-delivery, driven by breastfeeding-related elevations in prolactin that suppress ovulation.

Polycystic Ovary Syndrome (PCOS)

PCOS is widely described as the most common cause of secondary amenorrhea in reproductive-age women. The World Health Organization's fact sheet on PCOS states that it affects a substantial share of women of reproductive age worldwide and that many affected women remain undiagnosed (WHO PCOS fact sheet, accessed 2025; check the page directly for the current prevalence figure, since WHO periodically updates these estimates). Diagnosis generally relies on a combination of irregular cycles, clinical or laboratory signs of excess androgen, and ovarian appearance on ultrasound, evaluated together rather than any single test alone.

Combined oral contraceptives and metformin are commonly used first-line options to help regulate cycles in PCOS, and lifestyle changes including modest weight reduction can restore ovulation in some women with PCOS and a higher body mass index. Exact response rates vary across studies and should not be quoted as a fixed percentage without checking current primary literature.

Thyroid Dysfunction

Both underactive and overactive thyroid function can disrupt the hormonal signaling loop between the brain and ovaries that governs ovulation. Because thyroid disease is common, inexpensive to test for, and treatable, a TSH level is one of the first tests ordered in any amenorrhea workup, alongside pregnancy testing and a prolactin level.

Elevated Prolactin (Hyperprolactinemia)

High prolactin can suppress the signaling needed for ovulation. A prolactin-secreting pituitary tumor (prolactinoma), the most common type of pituitary tumor, is one possible cause and is usually investigated with pituitary imaging when prolactin is substantially elevated. Dopamine agonist medications (such as cabergoline or bromocriptine) are the standard treatment and are generally effective at lowering prolactin and restoring cycles in most patients, though the exact response rate depends on tumor size and severity and should be discussed with the prescribing clinician rather than assumed from a general percentage. Nipple discharge unrelated to breastfeeding (galactorrhea), headaches, and visual field changes are symptoms that should prompt evaluation for a pituitary cause.

Hypothalamic Amenorrhea

Hypothalamic amenorrhea results from suppressed hormonal signaling from the brain, driven by a caloric deficit relative to energy needs, high exercise volume, significant psychological stress, or a combination of these. Low FSH, low LH, and low estradiol are the typical hormone pattern. The Endocrine Society has published clinical practice guidance recommending that nutritional rehabilitation and psychological support (including cognitive behavioral approaches) be central to treatment, with hormonal therapy considered as an adjunct for bone protection rather than a first-line fix, since restoring energy balance is what addresses the underlying cause. Readers should not treat any specific wording attributed to that guideline as a verified direct quotation here; the original guideline document should be consulted directly for its exact recommendations and grading.

Athletes and people with restrictive eating patterns are at elevated risk. The general clinical concept is that when caloric intake falls too far below what the body needs relative to lean mass and exercise, ovulatory function shuts down as an energy-conservation response.

Premature Ovarian Insufficiency (POI)

POI refers to loss of normal ovarian function before age 40. It is generally diagnosed with elevated FSH on more than one occasion, weeks apart, combined with several months of amenorrhea, following criteria set out by professional reproductive medicine societies. POI is uncommon but not rare, and it is distinct from normal, later-onset menopause. Hormone replacement therapy is generally recommended until at least the average age of natural menopause, both to control symptoms and to protect long-term bone and cardiovascular health, though the specific regimen and duration should be individualized with a clinician.

Anatomic and Structural Causes

Adhesions inside the uterus (Asherman syndrome), often following a prior dilation and curettage or infection, can physically block menstrual outflow. In adolescents, an imperforate hymen or vaginal septum can cause a similar blockage, producing cyclic pelvic pain without visible bleeding. These are usually diagnosed with imaging or direct visualization (hysteroscopy) and are often correctable with a procedure.

When Should You Actually Worry?

Missing one period after a stressful month is a different situation from missing three consecutive cycles with no clear explanation. The scenarios below are ones where waiting several months "to see if it resolves" is not the safest default.

Signs That Warrant Prompt Evaluation (Days, Not Months)

• A missed period plus a positive pregnancy test, to confirm the pregnancy is in the right location and exclude an ectopic pregnancy
• Three or more consecutive missed periods at any reproductive age
• Nipple discharge unrelated to breastfeeding (galactorrhea)
• Severe or worsening pelvic pain around the expected time of a period
• Hot flashes, vaginal dryness, or night sweats in someone under 40
• Rapid unintentional weight loss or other signs of disordered eating
• New or worsening hair growth in a male-pattern distribution, voice changes, or other signs of androgen excess
• Headaches accompanied by visual changes

Why the Bone Density Question Matters

Estrogen deficiency lasting several months or longer is associated with reduced bone density in observational studies of women with hypothalamic amenorrhea, since estrogen has a protective effect on bone. This is a real and clinically relevant concern, but the exact magnitude of bone loss at a given duration of amenorrhea varies across studies and should not be reduced to a single number without checking the specific study population and methodology. In practice, many guidelines suggest considering a bone density scan (DXA) once amenorrhea has lasted roughly six months, particularly when low estrogen is suspected as the cause.

If You Are Trying to Conceive

Amenorrhea generally means no ovulation is occurring, so conception is not possible during that time. Women trying to become pregnant are often advised to seek evaluation sooner than the general six-month threshold, sometimes after around three months of absent periods, because time matters more when fertility is a current goal. Ovulation induction and other fertility treatments require confirming the underlying cause first, since the right treatment differs by diagnosis (for example, PCOS versus hypothalamic amenorrhea are treated very differently).

How Missed Periods Are Typically Diagnosed

Diagnosis generally moves from history and a small set of blood tests toward more targeted testing, with the goal of finding the simplest explanation before pursuing advanced studies.

Step 1: Pregnancy Test, TSH, and Prolactin

Nearly every evaluation begins with a pregnancy test, a TSH level, and a prolactin level, because together these three inexpensive tests identify a meaningful share of secondary amenorrhea cases without further workup.

Step 2: FSH, LH, and Estradiol

• FSH clearly elevated with low estradiol suggests ovarian insufficiency or failure.
• FSH and LH both low with low estradiol suggests a hypothalamic or pituitary cause.
• An elevated LH-to-FSH ratio with signs of excess androgen supports PCOS.
• Estradiol in a more typical range with missed periods and no other clear cause may suggest anovulation without significant estrogen deficiency.

These are drawn early in a spontaneous or induced bleed for the most interpretable result, and are always interpreted alongside symptoms and exam findings, not in isolation.

Step 3: Pelvic Ultrasound

A transvaginal ultrasound looks at ovarian appearance, uterine structure, and endometrial thickness. It supports a PCOS diagnosis when combined with cycle history and androgen findings, but ovarian appearance alone does not diagnose PCOS.

Step 4: Additional Testing Based on Clinical Suspicion

HealthRX.com missed-period triage framework. This table is an original organizing tool built for this page from the clinical patterns described above. It is not a validated clinical scoring system and does not replace a clinician's judgment; it is meant to help a reader decide how quickly to act and what to expect at a visit.

Treatment Approaches by Cause

There is no single treatment for amenorrhea. Treatment targets the underlying cause, and treating the missed period itself (for example, with a hormone that simply produces bleeding) without establishing the diagnosis can delay finding something that needs a different approach.

PCOS. Combined hormonal contraceptives are commonly used to regulate cycles, suppress excess androgen, and protect the uterine lining from unopposed estrogen exposure. For those who prefer not to use estrogen, cyclic progestin can protect the uterine lining while other issues are addressed. Modest weight change in either direction can meaningfully affect ovulation in PCOS, though individual response varies.

Hypothalamic amenorrhea. Addressing the energy deficit, through increased caloric intake, reduced exercise volume, or psychological support, is the primary treatment approach recommended by the Endocrine Society's guidance. Hormonal therapy may be added for bone protection during recovery but does not by itself fix the underlying hormonal suppression.

Elevated prolactin / prolactinoma. Dopamine agonist medications are standard treatment and are generally effective at normalizing prolactin and restoring cycles for most patients, over a timeframe of weeks to a few months, though this should not be treated as a guaranteed or universal outcome.

POI. Hormone therapy (or combined oral contraceptives as an alternative) is generally recommended until roughly the average age of natural menopause, to support bone and cardiovascular health, following guidance from reproductive medicine societies. Regimens are individualized.

Anatomic causes. Surgical correction of an imperforate hymen, vaginal septum, or cervical stenosis is often straightforward and curative. Adhesions from Asherman syndrome are often treated with hysteroscopic removal of scar tissue, with good rates of restored menstrual flow in milder cases, though severe disease can require more than one procedure.

Lifestyle and Medication Factors

Cycle disruption does not always indicate disease.

Body weight and energy intake. Both a very low body weight and rapid weight loss can suppress the hormonal signaling that drives ovulation, since the body interprets a large caloric deficit as a signal to conserve energy rather than support reproduction. Excess weight, by contrast, can raise insulin levels in ways that increase ovarian androgen production and contribute to PCOS-related anovulation.

Exercise volume. High training volumes, particularly in endurance and aesthetic sports, are associated with higher rates of hypothalamic amenorrhea. The "female athlete triad" concept (low energy availability, low bone density, and menstrual dysfunction occurring together) is a recognized pattern that sports medicine organizations recommend screening for in athletes missing periods.

Psychological stress. Stress hormones can directly inhibit the signaling that drives ovulation. Severe acute stress can delay or skip a small number of cycles, and cycles generally return within a few months once the stressor resolves. If periods do not return within a few months after a stressor has clearly resolved, evaluation for another cause is reasonable rather than continuing to wait.

Medications. Several common medications affect cycle regularity, including antipsychotics (through prolactin elevation), injectable and intrauterine progestin-only contraceptives (which commonly cause reduced or absent bleeding as an expected effect, not a sign of a problem), GnRH agonist medications used for endometriosis (which intentionally suppress cycles), and chronic opioid use (which can suppress the hormonal signaling needed for ovulation). Tell your clinician about every medication and supplement you take before assuming amenorrhea has an unknown cause.

Special Situations

Adolescents. Cycles are normally irregular for roughly the first two years after a first period, and missing one or two periods in that window is expected. Any adolescent who has not had a first period by age 15 with otherwise normal puberty should be referred for evaluation, since some causes benefit from earlier diagnosis.

Perimenopause. Women in their 40s who begin missing periods may be entering the menopausal transition. Ovulation can still occur even with irregular cycles during this transition, so contraception remains necessary until 12 consecutive months without a period confirm menopause. POI should still be considered and excluded in women under 45 with rising FSH and missed periods, since perimenopause and POI are managed differently.

GLP-1 receptor agonist medications. There are early reports and some survey-based research suggesting that meaningful weight loss on medications such as semaglutide or tirzepatide can improve cycle regularity in some women with obesity-related PCOS, plausibly through reduced insulin and androgen levels rather than a direct hormonal effect of the drug itself. This is an evolving area, and any claim about a specific proportion of women affected should be checked against the current primary literature before being treated as established. If your cycles change after starting a GLP-1 medication, mention it to the prescribing clinician rather than assuming it is either expected or unrelated.

What Is Established, What Is Plausible, and What Is Not Settled

Established: Pregnancy should always be excluded first. Three or more consecutive missed periods, or no first period by age 15 with normal puberty, are widely used thresholds for starting an evaluation. TSH and prolactin are standard early tests. Estrogen deficiency over a period of months is linked to reduced bone density in research on hypothalamic amenorrhea and POI. Hormone therapy is standard for POI to protect long-term bone and cardiovascular health.

Plausible but not fully settled for every reader: Exact percentages for how often specific treatments restore cycles (weight loss in PCOS, dopamine agonists for prolactinoma, GLP-1 medications and cycle regularity) vary across studies and populations, and should be treated as general directional evidence rather than a number that applies to any individual person.

Not established from the material available for this page: A precise duration-of-amenorrhea-to-bone-loss curve, a specific prevalence figure for Turner syndrome among primary amenorrhea cases, and an exact percentage of thyroid disease among secondary amenorrhea cases are the kinds of numbers that require verification against the specific primary study before they are published as fact. This draft intentionally avoids stating those exact figures pending that verification.

Questions Readers Actually Ask

A Note on the Sources Behind This Page

Several precise statistics that commonly appear in articles about missed periods (exact percentages for thyroid disease prevalence in secondary amenorrhea, exact bone density loss per month of amenorrhea, exact response rates to specific medications) could not be verified against a confirmed, correctly matched primary source for this draft and have been described qualitatively instead. Anyone updating this page with a specific number should link that number to the exact paper or guideline that reports it, not to a citation that merely shares a related topic.